“new-enterprise-associates” Archives

Entry Author Date Location
Sentry Receives $9,000,000 Series A Round 06/24/16 San Francisco
Annexon Biosciences Lands $44,000,000 Series B Funding Round 06/23/16 San Francisco
Gladly Obtains $27,000,000 New Financing Round 06/22/16 San Francisco
Plaid Technologies Lands $44,000,000 Series B Financing 06/20/16 San Francisco
Tigera Garners $13,000,000 Series A Financing Round 06/20/16 San Francisco
Node Obtains $7,500,000 New Funding Round 06/17/16 San Francisco
Mersana Therapeutics Receives $33,000,000 Series C Financing 06/16/16 Boston
illusive networks Obtains $3,000,000 Series B Funding Round 05/16/16 New York
Forter Lands $32,000,000 Series C Financing 04/22/16 San Francisco
Nginx Lands $8,000,000 New Round 04/21/16 San Francisco
Waltz Networks Receives $8,150,000 Series A Financing 04/20/16 San Francisco
FusionOps Lands $25,000,000 Series C Funding Round 04/19/16 San Francisco
Imara Lands $31,000,000 Series A Round 04/15/16 San Francisco
Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara 04/14/16 Boston
Veriflow Garners $2,900,000 Seed Funding Round 04/11/16 San Francisco
Lumos Pharma Raises $34M to Fund Clinical Trials for CTD Drug 04/06/16 Texas
Lumos Pharma Receives $34,000,000 Series B Round 04/06/16 Texas
Envisia Gets $16.5M More to Back Extended-Release Eye Drugs 03/23/16 Raleigh Durham
Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs 03/23/16 Boston
Landit Receives $2,000,000 New Financing Round 03/03/16 New York
Paysa Obtains $4,000,000 Seed Financing Round 02/25/16 San Francisco
ClearMetal Garners $3,000,000 Seed Funding Round 02/25/16 San Francisco
Synlogic Nabs $40M, Prepares To Put Modified Microbes Into Patients 02/17/16 Boston
Synlogic Obtains $40,000,000 Series B Round 02/17/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
DataRobot Obtains $33,000,000 Series B Round 02/11/16 Boston
ThirdLove Secures $8,000,000 Series A Funding 02/02/16 San Francisco
CRISPR: The Path to Clinical Trials 01/29/16 Boston
BloomReach Receives $56,000,000 Series D Funding 01/29/16 San Francisco
Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug 01/27/16 Boston
Page 2 of 22 « previous page · next page »